Ischemic delayed neuronal death: Role of the cysteine proteases calpain and cathepsins

Neuropathology

Volumn 19, Issue 4, 1999, Pages 356-365

  Tontchev, Anton B ^a   Yamashima, Tetsumori ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Brain ischemia; Calpain; Cathepsin; Delayed neuronal death

Indexed keywords

CALCIUM ION; CALPAIN; CATHEPSIN; CYSTEINE PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOSOL; HIPPOCAMPUS; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVIEW; SIGNAL TRANSDUCTION; TRANSIENT ISCHEMIC ATTACK;

EID: 0033398499     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.1999.00259.x     Document Type: Review

References (82)

1. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239: 57-69.
2. Pulsinelli WA, Brierly JB, Plum F. Temporal profile of neuronal damage in a model of transient brain ischemia. Ann Neurol 1982; 11: 491-498.
3. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medical temporal region: Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986; 6: 2950-2967.
4. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987; 37: 1281-1286.
5. Deshpande JK, Siesjö BK, Wieloch T. Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J Cereb Blood Flow Metab 1987; 7: 89-95.
6. Nitatori T, Sato N, Waguri S et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following cerebral ischemia is apoptosis. J Neurosci 1995; 15: 1001-1011.
7. Li Y, Chopp M, Powers C. Granule cell apoptosis and protein expression in hippocampal dentate gyrus after forebrain ischemia in the rat. J Neurol Sci 1997; 150: 93-102.
8. Kristián T, Siesjö BK. Calcium in ischemic cell death. Stroke 1998; 29: 705-718.
9. Martins E, Yanase H, Sakai K et al. Accumulation of calcium and loss of potassium in the hippocampus following transient cerebral ischemia: a proton microprobe study. J Cereb Blood Flow Metab 1988; 8: 531-538.
10. 2+ and energy levels during in vitro ischemia in the gerbil hippocampal slice. J Neurochem 1994; 62: 626-634.
11. 2+ influx in the pathogenesis of delayed neuronal death after brief forebrain ischemia in gerbils. Brain Res 1993; 613: 181-192.
12. Colbourne F, Li H, Buchan AM et al. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke 1999; 30: 662-668.
13. 2 levels in gerbil hippocampus. Neurosci Res 1992; 15: 305-309.
14. 2+ mobilization induced by hypoxia-hypoglycemia in the monkey hippocampal slices. Biochem Biophys Res Commun 1994; 205: 1843-1849.
15. Nomura Y. Involvement of glial NO synthase/NO in neuronal apoptosis in the brain. Neuropathology 1999; 19: 1-9.
16. 2 and calpain responses prior to delayed neuronal death in monkeys. Eur J Neurosci 1996; 8: 1932-1944.
17. Yamashima T, Kohda Y, Tsuchiya K et al. Inhibition of ischemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 1998; 10: 1723-1733.
18. Tsuchiya K, Kohda Y, Yoshida M et al. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Exp Neurol 1999; 155: 187-194.
19. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J 1997; 328: 721-732.
20. Croall DE, Demartino GN. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 1991; 81: 813-847.
21. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997; 59: 63-88.
22. Keppler D, Sameni M, Moin K et al. Tumor progression and angiogenesis: cathepsin & Co. Biochem Cell Biol 1996; 74: 799-810.
23. Villa PG, Henzel WJ, Sensenbrenner M et al. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci 1998; 111: 713-722.
24. Roberts-Lewis JM, Savage MJ, Marcy VR et al. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons of the ischemic gerbil brain. J Neurosci 1994; 14: 3934-3944.
25. Pike BR, Zhao X, Newcomb JK et al. Regional calpain and caspase-3 proteolysis of α-spectrin after traumatic brain injury. Neuroreport 1998; 9: 2437-2442.
26. Posmantur RM, Zhao X, Kampfl A et al. Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats. Neurochem Res 1998; 23: 1265-1276.
27. Canu N, Dus L, Barbato C et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 1998; 18: 7061-7074.
28. Gregoriou M, Willis AC, Pearson MA et al. The calpain cleavage sites in the epidermal growth factor receptor kinase domain. Eur J Biochem 1994; 223: 455-464.
29. Watt F, Molloy PL. Specific cleavage of transcription factors by the thiol protease, m-calpain. Nucl Acid Res 1993; 21: 5092-5100.
30. Neumar RW, DeGracia DJ, White BC et al. Eukaryotic initiation factor 4E degradation during brain ischemia. J Neurochem 1995; 65: 1391-1394.
31. Choi YH, Lee SJ, Nguyen P et al. Regulation of cyclin Dl by calpain protease. J Biol Chem 1997; 272: 28479-28484.
32. Kubbutat MH, Vousden KH. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 1997; 17: 460-468.
33. Kimura Y, Koga H, Araki N et al. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Nat Med 1998; 4: 915-922.
34. Croall DE, Chacko S, Wang Z. Cleavage of caldesmon and calponin by calpain: substrate recognition is not dependent on calmodulin binding domains. Biochim Biophys Acta 1996; 1298: 276-284.
35. Porn-Ares MI, Samali A, Orrenius S. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ 1998; 5: 1028-1033.
36. Walker G, Pfeilschifter J, Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J Biol Chem 1997; 272: 16679-16687.
37. Tompa P, Baki A, Schad E et al. The calpain cascade, μ-calpain activates m-calpain. J Biol Chem 1996; 271: 33161-33164.
38. Mellgren RL, Lu Q. Selective nuclear transport of mu-calpain. Biochem Biophys Res Commun 1994; 204: 544-550.
39. Creemers LB, Hoeben KA, Jansen DC et al. Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. Matrix Biol 1998; 16: 575-584.
40. Lambert Vidmar S, Lottspeich F et al. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin. Eur J Biochem 1991; 201: 71-77.
41. Williams KR, Williams ND, Konigsberg W et al. Acidic lipids enhance cathepsin D cleavage of the myelin basic protein. J Neurosci Res 1986; 15: 137-145.
42. Banay-Schwartz M, Dahl D, Hui KS, Lajtha A. The breakdown of the individual neurofilament proteins by cathepsin D. Neurochem Res 1987; 12: 361-367.
43. Johnson GV, Litersky JM, Whitaker JN. Proteolysis of microtubule-associated protein 2 and tubulin by cathepsin D. J Neurochem 1991; 57: 1577-1583.
44. McDermott JR, Gibson AM. Degradation of Alzheimer's β-amyloid protein by human cathepsin D. Neuroreport 1996; 7: 2163-2166.
45. Savage P, Shetty SS, Martin LL et al. Conversion of proendothelin-1 into endothelin-1 by asparylproteases. Int J Pept Protein Res 1993; 42: 227-232.
46. Jutras I, Reudelhuber TL. Prorenin processing by cathepsin B in vitro and in transfected cells. FEBS Lett 1999; 443: 48-52.
47. Spizz G, Blackshear PJ. Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme. J Biol Chem 1997; 272: 23833-23842.
48. Vancompernolle K, Van Herreweghe F, Pynaert G et al. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 1998; 438: 150-158.
49. Ishisaka R, Utsumi T, Yabuki M et al. Activation of caspase-3-like protease by digitonin-treated lysosomes. FEBS Lett 1998; 435: 233-236.
50. Wang KK, Postmantur R, Nadimpalli R et al. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 1998; 356: 187-196.
51. Saido TC, Nagao S, Shiramine M et al. Autolytic transition of μ-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. J Biochem 1992; 111: 81-86.
52. Bernstein HG, Kirschke H, Wiederanders B et al. Cathepsin B immunoreactive neurons in rat brain. J Hirnforsch 1988; 29: 17-19.
53. Bando Y, Kominami E, Katunuma N. Purification and tissue distribution of cathepsin L. Biochem Tokyo 1986; 100: 35-42.
54. Kohda Y, Yamashima T, Sakuda K et al. Dynamic changes of cathepsin B and L expression in the monkey hippocampus after transient ischemia. Biochem Biophys Res Commun 1996; 228: 616-622.
55. Ferrer I, Tortoise A, Macaya A et al. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil. Brain Pathol 1994; 4: 115-122.
56. Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A et al. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci 1996; 19: 109-114.
57. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316.
58. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
59. Chen J, Nagayama T, Jin K et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18: 4914-4928.
60. Ni B, Wu X, Su X et al. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons. J Cereb Blood Flow Metab 1998; 18: 248-256.
61. Himi T, Ishizaki Y, Murota S. A caspase inhibitor blocks ischemia-induced delayed neuronal death in the gerbil. Eur J Neurosci 1998; 10: 777-781.
62. Pike BR, Zhao X, Newcomb JK et al. Temporal relationship between de novo protein synthesis, calpain and caspase-3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures. J Neurosci Res 1998; 52: 505-520.
63. Waterhouse NJ, Finucane DM, Green DR et al. Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ 1998; 12: 1051-1061.
64. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
65. Hirsch T, Susin SA, Marzo I et al. Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol 1998; 14: 141-145.
66. Perez-Pinzon MA, Xu GP, Born J et al. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J Cereb Blood Flow Metab 1999; 19: 39-43.
67. Friberg H, Connern C, Halestrap AP et al. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem 1999; 72: 2488-2497.
68. Li PA, Uchino H, Elmer E et al. Amelioration by cyclosporin A of brain damage following 5-10 min of ischemia in rats subjected to preischemic hyperglycemia. Brain Res 1997; 753: 133-140.
69. Lee KS, Yanamoto H, Fergus A et al. Calcium-activated proteolysis as a therapeutic target in cerebrovascular disease. Ann N Y Acad Sci 1997; 825: 95-103.
70. Lee KS, Frank S, Vanderklish P et al. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 1991; 88: 7233-7237.
71. Himi T, Ishizaki Y, Murota S. A caspase inhibitor blocks ischemia-induced delayed neuronal death in the gerbil. Eur J Neurosci 1998; 10: 777-781.
72. Schwartz RD, Yu X, Katzman MR et al. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J Neurosci 1995; 15: 529-539.
73. Kimura M, Saji M. Protective effect of a low dose of colchicine on the delayed cell death of hippocampal CAl neurons following transient forebrain ischemia. Brain Res 1997; 774: 229-233.
74. Tokime T, Nozaki K, Kikuchi H. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci Lett 1996; 206: 81-84.
75. Sasaki K, Oomura Y, Suzuki K et al. Acidic fibroblast growth factor prevents death of hippocampal CA1 pyramidal cells following ischemia. Neurochem Int 1992; 21: 397-402.
76. Miyazata T, Matsumoto K, Ohmichi H et al. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 1998; 18: 345-348.
77. Wen TC, Takaka J, Peng H et al. Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field. J Exp Med 1998; 188: 635-649.
78. Nicotera P, Leist M, Manzo L. Neuronal cell death: a demise with different shapes. Trends Pharmacol Sci 1999; 20: 46-51.
79. Martin LJ, Al-Abdula NA, Brambrink AM et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998; 46: 281-309.
80. Shimizu S, Eguchi Y, Kamiike W et al. Retardation of chemical-induced necrotic death by bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogens 1996; 12: 2045-2050.
81. Suzuki A. Amyloid β-protein induces necrotic cell death mediated by ICE cascade in PC12 cells. Exp Cell Res 1997; 234: 507-511.
82. Higuchi M, Honda T, Proske RJ et al. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 1998; 26: 2753-2760.